Brown Advisory’s Cytosorbents Corp CTSO Stock Holding History

Brown Advisory’s Portfolio CTSO Stock Details CTSO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-18,200	Closed	-$145K	–	1090
2020 Q4	$145K	Hold	18,200	–	–	﹤0.01%	984
2020 Q3	$145K	Hold	18,200	–	–	﹤0.01%	928
2020 Q2	$180K	Hold	18,200	–	–	﹤0.01%	900
2020 Q1	$141K	Hold	18,200	–	–	﹤0.01%	888
2019 Q4	$70K	Buy	+18,200	New	+$79.4K	﹤0.01%	1015

Other funds holding CTSO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Skylands Capital Milwaukee, Wisconsin $763M AUM 26.49% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Brown Advisory's CTSO Position: Q1 2021 in Review

Brown Advisory sold out of Cytosorbents Corp (CTSO) in Q1 2021, closing a stake of 18,200 shares — an estimated $145K sold.

Brown Advisory first reported a position in CTSO in Q4 2019 and held it in 5 quarters. The position peaked at $180K in Q2 2020. 96 funds tracked by Wall St. Rank hold CTSO as of Q1 2021.

Brown Advisory reported no remaining Cytosorbents Corp position as of Q1 2021 after selling out during the quarter.
Brown Advisory sold 18,200 Cytosorbents Corp shares in Q1 2021, an estimated $145K.
Brown Advisory first reported a position in Cytosorbents Corp in Q4 2019 and held it in 5 quarters.
Brown Advisory's Cytosorbents Corp position peaked at $180K in Q2 2020.
96 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q1 2021.

Based on Brown Advisory's 13F filing for Q1 2021, filed 14 May 2021.